NovoPath Announces Partnership with McKesson to Provide Anatomic Pathology Solution
This makes perfect sense for the LIS space. McKesson needed an AP solution to add to their portfolio and increases NovoPath's presence in laboratories under McKesson's corporate strategy.
Princeton, NJ (PRWEB) August 30, 2012
NovoPath, a market-leading provider of anatomic pathology software solutions, today announced a strategic partnership with McKesson, a healthcare services and information technology leader. As part of the new agreement, McKesson plans to propose the NovoPath Anatomic Pathology Solution in conjunction with its advanced laboratory offering and its integrated health information system. The partnership is expected to benefit providers by offering the market an alternative solution that combines NovoPath’s deep expertise in anatomic pathology with McKesson’s best-of-breed laboratory solutions.
In addition to further extending NovoPath’s considerable presence in the anatomic pathology market, this agreement also supports McKesson’s Better Health 2020 strategy to enable better business, care and connectivity across the healthcare continuum including laboratories throughout the country.
Delivering enhanced communications, productivity and accuracy to pathology lab professionals nationwide, NovoPath is a comprehensive workflow and reporting lab information software system specifically designed to support the unique needs of the anatomic pathology laboratory. The NovoPath solution has been installed in small, medium and large hospitals, as well as specialty practice anatomic pathology laboratories, and local, regional and national reference labs.
“We are excited about this new relationship with NovoPath, which has a track record of exceptional service and product offerings for the anatomic pathology laboratory market,” said John Yount, vice president, Lab Solutions.
Both companies look forward to providing a comprehensive anatomic pathology solution that complements McKesson’s suite of laboratory solutions.
“This partnership enables NovoPath to provide McKesson customers and the larger market with a tightly integrated anatomic pathology solution,” commented Rick Callahan, NovoPath’s vice president of sales and marketing. “This integration offers laboratories the best of both worlds; a seamless integration of a best-of-breed with an outstanding enterprise-wide solution.”
About NovoPath, Inc. NovoPath, Inc. develops and markets software solutions for the Anatomic Pathology Laboratory market segment that includes local, regional, national, in-house laboratories as well as community and university teaching hospitals and medical centers. Since the release of its flagship product in 1999, NovoPath, Inc. has focused exclusively on Anatomic Pathology. NovoPath's mission is to provide unique and unparalleled solutions and services to all aspects of the Anatomic Pathology sector in a way that improves workflow, reduces the probability of human error, ensures results accuracy for greater patient safety, protects patient confidentiality, and above all, produces more precise and informative diagnostic outcomes. More information is available at http://www.NovoPath.com.
About McKesson McKesson Corporation, currently ranked 14th on the FORTUNE 500, is a healthcare services and information technology company dedicated to helping its customers deliver high-quality healthcare by reducing costs, streamlining processes, and improving the quality and safety of patient care. Over the course of its 178-year history, McKesson has grown by providing pharmaceutical and medical-surgical supply management across the spectrum of care; healthcare information technology for hospitals, physicians, homecare and payers; hospital and retail pharmacy automation; and services for manufacturers and payers designed to improve outcomes for patients.
Read the full story.
